About Bryogen
Bryogen is a Healthcare company based in Delhi (India) founded in 2010 by Rohit Tripathi. Manufacturer of generic solid and liquid dosage forms. It operates on a Traditional Pharmaceuticals model. Its chief executive, as recorded, is Sudhakar Arya. Its Indian entity Bryogen Pharmaceuticals Private Limited reported revenue of ₹13.32 Cr. Bryogen offers products and services including Bryogen Platform. Its focus areas include Traditional Pharmaceuticals, Generics, Companies and Diversified.
Company details
Bryogen operates with a Traditional Pharmaceuticals model, focusing on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of generic solid and liquid dosage forms. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Delhi, India
- Founders Rohit Tripathi
- SectorsHealthcare
- Website bryogen.in
- Legal Name Bryogen Pharmaceuticals Private Limited
- Date of Incorporation 02 Dec, 2010
- Jurisdiction Gurgaon, Haryana, India
- Annual Revenue₹13.32 Cr
FY 2025 · +108% YoY
- Net Profit₹2.75 Cr
FY 2025 · 21% margin
- EBITDA₹3.94 Cr
FY 2025 · 30% margin
Associated legal entities of Bryogen
Bryogen operates through Bryogen Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bryogen Pharmaceuticals Private Limited CIN U24232HR2010PTC041648 | Active | 02 Dec 2010 | Gurgaon, Haryana | ₹13.3 Cr | 2 | View details |
Products & Services of Bryogen
Bryogen offers a comprehensive portfolio of products and services, including Bryogen Platform.
Manufacturer of generic solid and liquid dosage forms
Board of directors of Bryogen Pharmaceuticals Private Limited (Bryogen)
Bryogen Pharmaceuticals Private Limited is the primary company behind Bryogen. The board of Bryogen Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Rohit Tripathi, appointed in 2010. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rohit Tripathi DIN 03306259 | Director | 02 Dec 2010 | 15 yrs 11 mo | Bryogen Pharmaceuticals Private Limited |
| Manish Tripathi DIN 07206170 | Director | 08 Feb 2016 | 10 yrs 9 mo | Bryogen Pharmaceuticals Private Limited |
People of Bryogen
2 people are tracked at Bryogen (2 in leadership).
| Name | Role | Group |
|---|---|---|
| CEO & Director | Leadership | |
| Co-Founder & Director | Leadership |
Complete people profiles for Bryogen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Bryogen
Figures of Bryogen Pharmaceuticals Private Limited, the primary company behind Bryogen, for FY 2025. Revenue was ₹13.32 Cr (+108% year on year). Net profit was ₹2.75 Cr (21% margin). EBITDA was ₹3.94 Cr (30% margin). Revenue has grown at a compounded annual rate of +30% over three years and +32% over five years.
- ₹13.32 CrRevenue · FY 2025 · +108% YoY
- ₹2.75 CrNet profit · 21% margin
- ₹3.94 CrEBITDA · 30% margin
- ₹15 LakhPaid-up capital
- +30%Revenue CAGR, 3 years
- +32%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Bryogen Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Bryogen
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bryogen
Bryogen was founded in 2010.
Bryogen is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Sudhakar Arya is the CEO of Bryogen, as recorded in our data.
The primary company behind Bryogen, Bryogen Pharmaceuticals Private Limited, reported revenue of ₹13.32 Cr for FY 2025, up 108% year on year.
Bryogen operates with a Traditional Pharmaceuticals model, focusing on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of generic solid and liquid dosage forms. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Bryogen offers Bryogen Platform.
Bryogen operates through Bryogen Pharmaceuticals Private Limited.
The legal entities of Bryogen currently have 2 directors, including Rohit Tripathi, Manish Tripathi.